Further functional validation of increased susceptibility to CHD development is also needed to confirm a definitive role of rs5418 site mutations in the GLUT4 gene and elucidate the effects of these mutations on CHD pathogenesis or etiology. This evidence concerns the gene SLC2A4 and coronary artery disorder.